A multi-center, phase II study to evaluate efficacy and safety of perioperative chemotherapy with fluorouracil, leucovorin, oxaliplatin, docetaxel (FLOT) and trastuzumab in combination with toripalimab in patients with HER2 positive locally advanced gastric or esophagogastric junction adenocarcinoma
Ongoing
This study is a prospective, single arm, multi-center phase II clinical trial designed to evaluate the efficacy and safety of perioperative chemotherapy with FLOT regimen and trastuzumab in combination with toripalimab in participants with resectable HER2 positive locally advance…
Phase 2 • Sponsor: Yu jiren
Last updated Sep 09, 2026 16:00 UTC